Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Attorney-Client Privilege on the Rebound?

Related Content

SEC Speaks Conference 2024

In This Issue: In re Sears Hometown and Outlet Stores, Inc. Stockholder Litigation, 2024 WL 262322 (Del. Ch. Jan. 24, 2024); Mi v. Waterdrop Inc., 2024 WL 159191 (2nd Cir. Jan. 16, 2024).

In This Issue: Goodwin Again Secures Dismissal of Putative Securities Class Action for Plug Power Inc.; Former Twitter Stockholder Denied Mootness Fees

In This Issue: DC Court Orders Covington to Disclose Client Names to SEC; SDNY Finds No Duty to Disclose Potential Loss of Clients in Olo Class Action

Supreme Court Delivers Key Defense Victory by Limiting Section 11 Claims in Direct Listings — and Again Calling for a Rigid Application of the Tracing Requirement

Second Circuit Upholds Dismissal of AstraZeneca Investor Suit

Blueprint of the Advisers Act-Related SPAC Enforcement Actions So Far

ACI's 19th FCPA & Anti-Corruption for the Life Sciences Industry

2023-2024 Key Trends and Updates: Securities Litigation Against Life Sciences Companies

Goodwin CLE Days 2024

Securities Regulations To Watch In 2024 (Law360)

Grant Fondo Named a 2023 Top White Collar Lawyer by Daily Journal

The US Supreme Court Could Reshape the Sec’s Powers — and How the Agency Approaches Crypto (Blockworks)

Former SEC Lawyer Joins Goodwin (IFLR)

Leading Capital Markets Partner David Lynn Joins Goodwin to Chair Public Company Advisory Practice

Securities Litigation & SEC Enforcement

White Collar Defense